-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroSense Therapeutics Announces Positive Initial Results from Phase 2 Trial of PrimeC for Alzheimer's Disease

Reuters·09/10/2025 18:30:28

Please log in to view news